ClearNote Health to Showcase Leading Early Detection Results for Avantect® Pancreatic Cancer Test at Digestive Disease Week 2026 ClearNote Health, a biotechnology company focused on advancing early cancer detection, has announced an extensive lineup of presentations for the upcoming Digestive…
Ray Therapeutics Secures PRIME Designation from the European Medicines Agency for RTx-015 Targeting Retinitis Pigmentosa Ray Therapeutics (RayTx), a clinical-stage biopharmaceutical company focused on developing innovative therapies for vision restoration, has announced that the European Medicines Agency (EMA) has granted…
Sapient Unveils Advanced Tumor Protein Mapping Platform to Decode Functional Biology Across Key Dimensions in Human Cancers Sapient, an emerging leader in multi-omics data generation and biomarker discovery, has unveiled a major advancement in translational oncology research with the launch…
GSK Reports U.S. Food and Drug Administration Grants Breakthrough Therapy Designation and Priority Review Acceptance for Bepirovirsen in Chronic Hepatitis B as Potential First-in-Class Treatment Ionis Pharmaceuticals and its partner GSK have reached a significant regulatory milestone in the development…
Janux Therapeutics Halts Development of JANX008 Program Janux Therapeutics, Inc. has announced its decision to discontinue further clinical development of JANX008, an investigational EGFR-targeted Tumor Activated T Cell Engager (TRACTr) therapy, following completion of early-stage clinical evaluation and an internal…
Supported by Over $1 Billion in Investment, PCI Pharma Services Unveils Major Expansion of U.S. Sterile Fill-Finish and Drug–Device Combination Capabilities PCI Pharma Services has unveiled an extensive series of infrastructure investments aimed at significantly strengthening its sterile fill-finish capabilities…
vVARDIS Secures Strategic Investment from Apollo, Reaching Unicorn Valuation vVARDIS Holding AG, a rapidly expanding dental medtech innovator focused on transforming the way tooth decay is treated, has announced a strategic minority investment from funds managed by Apollo Global Management.…
Adagio Medical Reports Successful Pivotal Outcomes for vCLAS® Ventricular Ablation System Adagio Medical Holdings, Inc. has reported compelling six-month clinical outcomes from its pivotal FULCRUM-VT Investigational Device Exemption (IDE) trial, marking a significant milestone in the advancement of catheter ablation…
Dental Care Alliance Unveils Strategic Transaction to Bolster Financial Stability and Drive Long-Term Growth Dental Care Alliance (DCA), one of the largest dental support organizations in the United States, has announced a major financial restructuring agreement with its existing lender…
HealthPartners Highlights Ongoing Progress, Key Priorities, and Future Actions to Advance Simpler, More Affordable Health Care Amid a persistent rise in both medical and pharmacy costs, HealthPartners is stepping up its efforts to make health care more accessible, understandable and…
Bausch + Lomb Publishes Review on B Vitamins and Their Role in Reducing Risk and Progression of Age-Related Macular Degeneration Bausch + Lomb Corporation has announced the publication of a major scientific narrative review in the peer-reviewed journal Ophthalmology and…
AbbVie Chooses North Carolina as Site for $1.4 Billion Advanced Manufacturing Facility AbbVie has unveiled an ambitious new chapter in its long-term growth strategy with the announcement of a $1.4 billion investment to establish a cutting-edge pharmaceutical manufacturing campus in…